Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis
International Journal of Molecular Sciences · 23.04.2026 · 27 (9) · 3747
DOI: 10.3390/ijms27093747 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2026. Verfasst von Özben Özden und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul 34752, Türkiye. Hauptthemen laut MEDLINE: Trichomonas vaginalis, Metronidazole, Antimicrobial Peptides, Drug Resistance. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Trichomonas vaginalis is the causative agent of trichomoniasis, the most common non-viral sexually transmitted infection worldwide. In these cases, 5-Nitroimidazoles, particularly metronidazole (MTZ), remain the primary treatment option; however, resistance to MTZ has been increasingly reported. This study aimed to evaluate the in vitro activity of D-form synthetic antimicrobial peptides and investigate transcriptional differences associated with MTZ resistance and peptide treatment in T. vaginalis. D-form synthetic peptides (D-TN1, D-TN3, and D-TN6) developed in the R&D Laboratory of Acibadem University were tested against metronidazole-susceptible (T. vaginalis ATCC 30236) and metronidazole-resistant (T. vaginalis ATCC 50143) strains by minimum lethal concentration (MLC) assays. D-TN1 exhibited an MLC of 16 µg/mL in both strains, whereas D-TN3 and D-TN6 exhibited MLC values of 32 µg/mL and 16–32 µg/mL, respectively. Comparative transcriptomic analysis was conducted to investigate transcriptional differences. Differential gene expression analysis identified 3395 genes between the resistant and susceptible isolates and 3060 genes in the D-TN1-treated resistant isolate (FDR < 0.05, |log2FC| ≥ 1). D-TN1 treatment in the resistant isolate was associated with downregulation of ribosomal and metabolic pathways. If confirmed with further in vivo studies, this new antimicrobial peptide may become a new therapeutic alternative in the treatment of trichomoniasis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul 34752, Türkiye.
- Department of Medical Microbiology, Acibadem University School of Medicine, Istanbul 34752, Türkiye.
ORCID-Profile: Özben Özden, Tuba Polat, Özgür Kurt
Zitieren
APA
Özden, Ö., Polat, T., Kocagöz, T., & Kurt, Ö. (2026). Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis. International Journal of Molecular Sciences, 27(9), 3747. https://doi.org/10.3390/ijms27093747
Vancouver
Özden Ö, Polat T, Kocagöz T, Kurt Ö. Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis. International Journal of Molecular Sciences. 2026;27(9):3747. doi:10.3390/ijms27093747
BibTeX
@article{zden2026,
author = {Özden, Özben and Polat, Tuba and Kocagöz, Tanıl and Kurt, Özgür},
title = {Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {3747},
doi = {10.3390/ijms27093747}
}
EUVIMED